Ryan Drenan to Nicotinic Agonists
This is a "connection" page, showing publications Ryan Drenan has written about Nicotinic Agonists.
Connection Strength
1.500
-
Yan Y, Beckley NA, Kim VJ, Drenan RM. Differential Nicotinic Modulation of Glutamatergic and GABAergic VTA Microcircuits. eNeuro. 2019 Nov/Dec; 6(6).
Score: 0.678
-
Engle SE, Shih PY, McIntosh JM, Drenan RM. a4a6ß2* nicotinic acetylcholine receptor activation on ventral tegmental area dopamine neurons is sufficient to stimulate a depolarizing conductance and enhance surface AMPA receptor function. Mol Pharmacol. 2013 Sep; 84(3):393-406.
Score: 0.433
-
Arvin MC, Jin XT, Yan Y, Wang Y, Ramsey MD, Kim VJ, Beckley NA, Henry BA, Drenan RM. Chronic Nicotine Exposure Alters the Neurophysiology of Habenulo-Interpeduncular Circuitry. J Neurosci. 2019 05 29; 39(22):4268-4281.
Score: 0.161
-
Henderson BJ, Srinivasan R, Nichols WA, Dilworth CN, Gutierrez DF, Mackey ED, McKinney S, Drenan RM, Richards CI, Lester HA. Nicotine exploits a COPI-mediated process for chaperone-mediated up-regulation of its receptors. J Gen Physiol. 2014 Jan; 143(1):51-66.
Score: 0.112
-
Grady SR, Drenan RM, Breining SR, Yohannes D, Wageman CR, Fedorov NB, McKinney S, Whiteaker P, Bencherif M, Lester HA, Marks MJ. Structural differences determine the relative selectivity of nicotinic compounds for native alpha 4 beta 2*-, alpha 6 beta 2*-, alpha 3 beta 4*- and alpha 7-nicotine acetylcholine receptors. Neuropharmacology. 2010 Jun; 58(7):1054-66.
Score: 0.086
-
Bordia T, McGregor M, McIntosh JM, Drenan RM, Quik M. Evidence for a role for a6(*) nAChRs in l-dopa-induced dyskinesias using Parkinsonian a6(*) nAChR gain-of-function mice. Neuroscience. 2015 Jun 04; 295:187-97.
Score: 0.031